In vitro and ex vivo effects of aspirin in patients on a low-dose aspirin therapy

This publication has 21 references indexed in Scilit:

• Suppression of Thromboxane A₂but Not of Systemic Prostacyclin by Controlled-Release Aspirin
  New England Journal of Medicine, 1991
• Effects of acetylsalicylic acid in stroke patients evidence of nonresponders in a subpopulation of treated patients
  Thrombosis Research, 1991
• The Clinical Importance of Acquired Abnormalities of Platelet Function
  New England Journal of Medicine, 1991
• Long-term maintenance of thromboxane inhibition by two different aspirin regimens in patients with unstable angina
  Thrombosis Research, 1990
• Beta-lactam antibiotic-induced platelet dysfunction: evidence for irreversible inhibition of platelet activation in vitro and in vivo after prolonged exposure to penicillin
  Blood, 1990
• Secondary prevention of vascular disease by prolonged antiplatelet treatment
  BMJ, 1988
• Platelet-Mediated Bleeding Caused by Broad-Spectrum Penicillins
  The Journal of Infectious Diseases, 1987
• Effects of low doses of aspirin, 10 mg and 30 mg daily, on bleeding time, thromboxane production and 6-keto-PGF1α excretion in healthy subjects
  Thrombosis Research, 1987
• IMPROVED AORTOCORONARY BYPASS PATENCY BY LOW-DOSE ASPIRIN (100 mg DAILY)
  The Lancet, 1984
• Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
  Journal of Clinical Investigation, 1983